Imperial College London
Alternate

ProfessorEricAlton

Faculty of Medicine, National Heart & Lung Institute

Chair in Gene Therapy
 
 
 
//

Contact

 

+44 (0)20 7594 7929e.alton

 
 
//

Assistant

 

Miss Samia Soussi +44 (0)20 7594 7980

 
//

Location

 

Emmanuel Kaye BuildingRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Davies:2009:10.4187/aarc0493,
author = {Davies, JC and Alton, EW},
doi = {10.4187/aarc0493},
journal = {Respir Care},
pages = {606--617},
title = {Monitoring respiratory disease severity in cystic fibrosis.},
url = {http://dx.doi.org/10.4187/aarc0493},
volume = {54},
year = {2009}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Measurements of disease severity provide a guide for the physician to tailor therapies, for the patient and family to gauge progress, and are required for clinical trials. For many respiratory diseases, including cystic fibrosis, sensitive, noninvasive measurements are few, and some of those that are available are applicable only to certain subgroups of patients or lack sufficient sensitivity. We discuss currently available measurements in 4 groups: physiology, infection, inflammation, and radiology. For each group we highlight strengths and weaknesses, ask how we could improve upon these, and provide details of alternative methods.
AU  - Davies,JC
AU  - Alton,EW
DO  - 10.4187/aarc0493
EP  - 617
PY  - 2009///
SN  - 0020-1324
SP  - 606
TI  - Monitoring respiratory disease severity in cystic fibrosis.
T2  - Respir Care
UR  - http://dx.doi.org/10.4187/aarc0493
UR  - https://www.ncbi.nlm.nih.gov/pubmed/19393105
VL  - 54
ER  -
Download